NEW YORK (GenomeWeb) – Enzo Biochem today announced that it has received a favorable claim construction ruling that will govern 10 ongoing patent suits the firm has brought to defend three US patents.

The firm said the US District Court for the District of Delaware has adopted Enzo's proposed constructions for the majority of the disputed claim terms and rejected the defendants' argument that Enzo's US Patent No. 6,992,180 for phosphate-moiety labeled oligonucleotide reagents is invalid for indefiniteness.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.